Publications by authors named "R Wasmuth"

Claim this Profile
C
CD37 in acute myeloid leukemia: a novel surface target for drug delivery.
Erin Jeremy, Esthela Artiga, Sara Elgamal, Carolyn Cheney, Dalen Eicher, Ronni Wasmuth

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
Timothy L Chen, Bonnie Harrington, Jean Truxall, Ronni Wasmuth, Alexander Prouty

J Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia.
Lindsey T Brinton, Pu Zhang, Katie Williams, Daniel Canfield, Shelley Orwick, Ronni Wasmuth

J Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
Rajeswaran Mani, Girish Rajgolikar, Jessica Nunes, Kevan Zapolnik, Ronni Wasmuth

Cytotherapy· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia.
Lindsey T Brinton, Steven Sher, Katie Williams, Daniel Canfield, Shelley Orwick, Ronni Wasmuth

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis